Zenas BioPharma, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
ZBIO on Nasdaq
Industry
Pharmaceutical Preparations
Location
852 Winter Street, Suite 250, Waltham, MA

Insiders trading volume in the past year

Zenas BioPharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
InnoCare Pharma Inc. 10%+ Owner $111M Oct 7, 2025
Enavate Sciences GP, LLC 10%+ Owner $63.9M Sep 16, 2024
Fairmount Funds Management LLC Director $42M +$6.01M +16.7% Oct 7, 2025
Sr One Capital Management, Llc 10%+ Owner $36.4M +$2.4M +7.05% Oct 9, 2025
Patrick G. Enright Director $35.1M +$2.25M +6.86% Oct 9, 2025
Jason R. Nunn Director $22.3M +$1.2M +5.69% Oct 9, 2025
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10%+ Owner $13.6M Sep 16, 2024
Leon O. Moulder Jr Chief Executive Officer, Director $6.68M +$1.65M +32.9% Oct 7, 2025
Hongbo Lu Director $6.12M +$5M +447% Jun 10, 2025
Ting Xiao Director $77.6K +$77.6K Feb 7, 2025
John J. Orloff Director Jun 10, 2025
Orlando Oliveira Chief Commercial Officer Jun 10, 2025
Patricia L. Allen Director Jun 10, 2025
James P. Boylan Director Jun 10, 2025
Joseph L. Farmer President and Chief Operating Officer Jun 10, 2025
Lisa von Moltke Head of Research and Development and Chief Medical Officer Apr 15, 2025
Jennifer Fox Chief Financial Officer and Chief Business Officer Jun 10, 2025

Recent Insider Transactions by Companies or Individuals for Zenas BioPharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.